Beranda › Kanker Paru Non-Sel Kecil › Florida › Deltona
Uji klinis Kanker Paru Non-Sel Kecil di Deltona, FL
15 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Deltona (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Menerima pesertaFase 1/2
- Mid Florida Hematology And Oncology Center /ID# 273777, Orange City · 4 mi jauhnya
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Menerima pesertaFase 3
- Mid Florida Hematology and Oncology Center ( Site 0018), Orange City · 4 mi jauhnya
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Alpha Clinical Research Centers LLC, Orange City · 4 mi jauhnya
- Florida Cancer Specialists, Orange City · 4 mi jauhnya
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi jauhnya
- dan 1 lainnya
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Menerima pesertaFase 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi jauhnya
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Menerima pesertaFase 1/2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi jauhnya
Pan-tumor MRD Study
Menerima pesertaStudi observasional
- Mid Florida Cancer Centers, Orange City · 4 mi jauhnya
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Menerima pesertaFase 3
- Research Site, Orange City · 4 mi jauhnya
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Menerima pesertaFase 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi jauhnya
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Menerima pesertaFase 2/3
- Mid Florida Cancer Centers, Orange City · 4 mi jauhnya
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Menerima pesertaFase 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi jauhnya
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Menerima pesertaFase 2/3
- Local Institution - 007-926-B, Daytona Beach · 26 mi jauhnya
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Mid-Florida Hematology & Oncology Centers, P.A., Orange City · 4 mi jauhnya
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Research Site, Orange City · 4 mi jauhnya
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Menerima pesertaFase 1/2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi jauhnya
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Menerima pesertaFase 2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi jauhnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Deltona
- Obesitas11 studi
- Penyakit Alzheimer10 studi
- Diabetes Tipe 210 studi
- Kelebihan Berat Badan9 studi
- Kanker Payudara8 studi
- Kanker Paru8 studi
- Kanker (semua jenis)7 studi
- Kanker Metastatik5 studi
- PPOK5 studi
- Tekanan Darah Tinggi5 studi
- Melanoma5 studi
- Osteoartritis Lutut5 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.